Opinion

Video

Recent Updates for Second-Line Treatment Options in Lower-Risk MDS

The panel of experts review recent data updates for new agents being investigated in the second line in patients with lower-risk MDS.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Newsletter

    Stay up to date on the most recent and practice-changing oncology data